中药联合化疗治疗中晚期非小细胞肺癌的近期临床疗效分析(4)
[13]田希贵，刘德森，汪元玉，等.腺癌与其他类型非小细胞肺癌术后临床特点的差异及预后因素分析[J].中国癌症杂志，2017，27(3)：227-232.
[14]Putra A C，Eguchi H，Lee K L，et al.The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer[J].Plos One，2015，10(8)：e0134496.
[15]陈信庭，洪水强，赵崇瑜.益气养阴解毒方联合化疗治疗非小细胞肺癌临床研究[J].实用中医药杂志，2015，2(6)：546-547.
[16]于丽娜，胥科辉，王莉，等.益气养阴通络法联合化疗治疗晚期非小细胞肺癌31例临床观察[J].湖南中医杂志，2016，32(10)：54-56.
[17]Yang C.Clinical Research on Adjuvant Chemotherapy and Maintenance Therapy of Fuzheng Xiaoji Yin Treatment of Non-Small Cell Lung Cancer in Middle and Advanced Stage[J].China Journal of Chinese Medicine，2013.
[18]Liu J，Ruixia L I，Guo Z，et al.Clinical Observation of Elemene Combined with NP Chemotherapy for Advanced Non-small Cell Lung Cancer[J].Pract J Cancer，2015.
[19]Shen H，Zhao P.A Meta-analysis of Elemene emulsion plus platinum-based chemotherapy on advanced non-small cell lung cancer[J].Journal of Modern Oncology，2013.
[20]張蕴超，贾英杰，朱津丽，等.消岩汤联合榄香烯注射液治疗癌症恶病质41例临床观察[J].中医杂志，2016，57(7)：574-578., 百拇医药(周莉莉 张凤鸣 王红)
[14]Putra A C，Eguchi H，Lee K L，et al.The A Allele at rs13419896 of EPAS1 Is Associated with Enhanced Expression and Poor Prognosis for Non-Small Cell Lung Cancer[J].Plos One，2015，10(8)：e0134496.
[15]陈信庭，洪水强，赵崇瑜.益气养阴解毒方联合化疗治疗非小细胞肺癌临床研究[J].实用中医药杂志，2015，2(6)：546-547.
[16]于丽娜，胥科辉，王莉，等.益气养阴通络法联合化疗治疗晚期非小细胞肺癌31例临床观察[J].湖南中医杂志，2016，32(10)：54-56.
[17]Yang C.Clinical Research on Adjuvant Chemotherapy and Maintenance Therapy of Fuzheng Xiaoji Yin Treatment of Non-Small Cell Lung Cancer in Middle and Advanced Stage[J].China Journal of Chinese Medicine，2013.
[18]Liu J，Ruixia L I，Guo Z，et al.Clinical Observation of Elemene Combined with NP Chemotherapy for Advanced Non-small Cell Lung Cancer[J].Pract J Cancer，2015.
[19]Shen H，Zhao P.A Meta-analysis of Elemene emulsion plus platinum-based chemotherapy on advanced non-small cell lung cancer[J].Journal of Modern Oncology，2013.
[20]張蕴超，贾英杰，朱津丽，等.消岩汤联合榄香烯注射液治疗癌症恶病质41例临床观察[J].中医杂志，2016，57(7)：574-578., 百拇医药(周莉莉 张凤鸣 王红)